Add-on Acquisition • Life Science

Maravai Acquires MyChem

On January 28, 2022, Maravai acquired life science company MyChem for 240M USD

Acquisition Context
  • This is Maravai’s 4th transaction in the Life Science sector.
  • This is Maravai’s largest (disclosed) transaction.
  • This is Maravai’s 4th transaction in the United States.
  • This is Maravai’s 2nd transaction in California.

Explore All 3109 Add-on Acquisition Life Science Deals - Search the Database Free


M&A Deal Summary

Date January 28, 2022
Target MyChem
Sector Life Science
Buyer(s) Maravai
Deal Type Add-on Acquisition
Deal Value 240M USD
Advisor(s) BroadOak Capital Partners (Financial)
Morrison & Foerster (Legal)

Target Company

MyChem

San Diego, California, United States
MyChem is a privately held provider of proprietary, ultra-pure nucleotides to customers in the diagnostics, pharma, genomics, and research markets. MyChem products include modified nucleotides and other inputs used for mRNA synthesis. MyChem is based in San Diego, California.
Explore More Deals

Browse All 215,158 Deals

FILTER BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Search Free

Buyer Overview 1

Buyer

Maravai

San Diego, California, United States

Category Company
Founded 2020
Sector Life Science
Employees570
Revenue 259M USD (2024)
DESCRIPTION

Maravai is a life sciences company providing critical products to enable the development of drug therapies, diagnostics, and novel vaccines. Maravai’s companies provide products and services in the fields of nucleic acid synthesis and biologics safety testing to many biopharmaceutical, vaccines, diagnostics, and cell and gene therapy companies. Maravai was founded in 2020 and is based in San Diego, California.


Deal Context for Buyer #
Overall 4 of 5
Sector: Life Science 4 of 5
Type: Add-on Acquisition 4 of 4
State: California 2 of 2
Country: United States 4 of 4
Year: 2022 1 of 1
Size (of disclosed) 1 of 1
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2021-09-07 Vector Laboratories

Newark, California, United States

Vector Laboratories is a provider of life science products, including labeling and detection reagents, that help medical and scientific researchers visualize cells in experiments that are central to the understanding of cancer and other diseases. Vector Laboratories was founded in 1976 and is based in Newark, California.

Sell -
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2024-11-07 Officinae Bio - DNA and RNA business

Venice, Italy

Officinae Bio's DNA and RNA business generates libraries of precisely engineered UTRs (untranslated regions), optimizing efficacy and safety through enhanced translation and tissue-specificity. Officinae Bio's DNA and RNA business is based in Venice, Italy.

Buy -